Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Molecular Pharmacology
|
July 11, 1998
Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus
K A Berg, S Maayani, J Goldfarb, et al.
Pharmacology & Therapeutics
|
December 27, 2008
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
V J Aloyo, K A Berg, U Spampinato, et al.
Molecular Pharmacology
|
April 30, 1999
Novel actions of inverse agonists on 5-HT2C receptor systems
K A Berg, B D Stout, J D Cropper, et al.
Seizure
|
January 17, 2002
Morphological changes in the testis after long-term valproate treatment in male Wistar rats
L Sveberg Røste, E Taubøll, A Berner, et al.
British Journal of Pharmacology
|
July 6, 2013
Signalling profile differences: paliperidone versus risperidone
W P Clarke, T A Chavera, M Silva, et al.
Basic Life Sciences
|
January 1, 1988
Variation in expression of congenital cardiovascular malformations within and among families
J A Boughman, J A Astemborski, K A Berg, et al.
Neuroscience
|
December 13, 2006
Integrins regulate opioid receptor signaling in trigeminal ganglion neurons
K A Berg, G Zardeneta, K M Hargreaves, et al.
American Journal of Diseases of Children (1960)
|
December 1, 1989
Cardiac malformations in relatives of infants with hypoplastic left-heart syndrome
J I Brenner, K A Berg, D S Schneider, et al.
Molecular Pharmacology
|
May 1, 1994
5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms
K A Berg, W P Clarke, Y Chen, et al.
British Journal of Pharmacology
|
September 21, 2001
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity
K A Berg, J D Cropper, C M Niswender, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Molecular Pharmacology
|
July 11, 1998
Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus
K A Berg, S Maayani, J Goldfarb, et al.
Pharmacology & Therapeutics
|
December 27, 2008
Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors
V J Aloyo, K A Berg, U Spampinato, et al.
Molecular Pharmacology
|
April 30, 1999
Novel actions of inverse agonists on 5-HT2C receptor systems
K A Berg, B D Stout, J D Cropper, et al.
Seizure
|
January 17, 2002
Morphological changes in the testis after long-term valproate treatment in male Wistar rats
L Sveberg Røste, E Taubøll, A Berner, et al.
British Journal of Pharmacology
|
July 6, 2013
Signalling profile differences: paliperidone versus risperidone
W P Clarke, T A Chavera, M Silva, et al.
Basic Life Sciences
|
January 1, 1988
Variation in expression of congenital cardiovascular malformations within and among families
J A Boughman, J A Astemborski, K A Berg, et al.
Neuroscience
|
December 13, 2006
Integrins regulate opioid receptor signaling in trigeminal ganglion neurons
K A Berg, G Zardeneta, K M Hargreaves, et al.
American Journal of Diseases of Children (1960)
|
December 1, 1989
Cardiac malformations in relatives of infants with hypoplastic left-heart syndrome
J I Brenner, K A Berg, D S Schneider, et al.
Molecular Pharmacology
|
May 1, 1994
5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms
K A Berg, W P Clarke, Y Chen, et al.
British Journal of Pharmacology
|
September 21, 2001
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity
K A Berg, J D Cropper, C M Niswender, et al.
Page
of 5